BioCryst Pharmaceuticals Inc (MEX:BCRX)
MXN 175 (0%) Market Cap: 42.97 Bil Enterprise Value: 53.12 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 58/100

BioCryst Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript

May 12, 2026 / 08:40PM GMT
Release Date Price: MXN149.57
Tazeen Ahmad
Bofa Merrill Lynch Asset Holdings Inc - Analyst

Okay. Great. So good afternoon, everyone. Welcome back to the Bank of America Healthcare Conference. I'm Tazeen Ahmad. I'm one of the biotech analysts here at the bank. It's my pleasure to have with me our next presenting company, BioCryst Pharmaceuticals.

Sitting up here on stage with me are two members from the management team. We've got Babar Ghias who is the Chief Financial Officer; and Sandeep Menon, who is Chief Research and Development Officer.

Gentlemen, thank you for making the trip out West.

Babar Ghias
BioCryst Pharmaceuticals Inc - Chief Financial Officer, Head of Corporate Development

Thank you, Tazeen, and thanks for having us.

Questions & Answers

Tazeen Ahmad
Bofa Merrill Lynch Asset Holdings Inc - Analyst

So maybe as an overview, just give us a quick description of BioCryst as it stands today. Some people know it in various different forms, but talk to us about what you found appealing about it because you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot